Home
>
National Drug Code (NDC)
>
Androgel
Androgel - 0051-8462-31 - (Testosterone)
Drug Information of Androgel
| Product NDC: | 0051-8462 |
| Proprietary Name: | Androgel |
| Non Proprietary Name: | Testosterone |
| Active Ingredient(s): | 16.2 mg/g & nbsp; Testosterone |
| Administration Route(s): | TRANSDERMAL |
| Dosage Form(s): | GEL |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Androgel
| Product NDC: | 0051-8462 |
| Labeler Name: | AbbVie Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022309 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110429 |
Package Information of Androgel
| Package NDC: | 0051-8462-31 |
| Package Description: | 30 PACKET in 1 CARTON (0051-8462-31) > 1.25 g in 1 PACKET (0051-8462-12) |
NDC Information of Androgel
| NDC Code | 0051-8462-31 |
| Proprietary Name | Androgel |
| Package Description | 30 PACKET in 1 CARTON (0051-8462-31) > 1.25 g in 1 PACKET (0051-8462-12) |
| Product NDC | 0051-8462 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Testosterone |
| Dosage Form Name | GEL |
| Route Name | TRANSDERMAL |
| Start Marketing Date | 20110429 |
| Marketing Category Name | NDA |
| Labeler Name | AbbVie Inc. |
| Substance Name | TESTOSTERONE |
| Strength Number | 16.2 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient] |
